| Abstract: | The recognition that patients with rheumatoid arthritis are at a heightened risk of cardiovascular disease (CVD) events and mortality spans more than 2 decades, yet there continues to be debate as to who should screen this population for CVD risk. There are several challenges to regular screening of this population: limited time, the assumption that this problem is being addressed by the rheumatologist, and lack of awareness by primary care providers (PCP) of increased CVD risk. A collaborative approach between PCPs and rheumatologists is necessary to address the increased CVD risk and to treat these risk factors aggressively. |
